Citations

Mayo Clinic

Showing 10 of 108599 citations.

Early Markers of Angiogenesis and Ischemia during Bowel Conduit Neovascularization
Ciudad, Pedro , Torto, Federico Lo , Li, Yun-Fen , Nguyen, Doan-Minh, Chen, Hung‐Chi , Manrique, Oscar J. , Chen, Hung‐Chi , Wong, Alex K. , Chen, Pei‐Yu

Journal of Reconstructive Microsurgery | June 19, 2017 | Volume: 33 | Issue: 09 | Pages: 605-611

10.1055/s-0037-1603905 | PMID 28628933 Get It

Background Bowel flaps are a good and reliable method to restore the continuity of the aerodigestive tract. Radiated fields, contaminated recipient sites, or depleted recipient vessels may increase the risk for ischemic injury after transfer. During ischemic events, we believe that bowel conduits with serosa have a delayed neovascularization process at its new recipient site.We conducted an ischemia/reperfusion murine model to understand the difference among bowel conduits with and without serosa. Materials and Methods Two groups of rats were compared: control group (jejunal conduit with serosa) and a target group (jejunal conduit without serosa). These conduits were harvested from the peritoneal cavity and transferred into a subcutaneous pocket. After 72 hours of transfer and pedicle ligation, histological changes related to ischemia/reperfusion were assessed. In addition, tissue markers of angiogenesis (CD34), ischemia (lactate dehydrogenase [LDH]), and inflammation (interleukin [IL]-1β and IL-6) were analyzed. Results Two groups (n = 20) of male rats were analyzed. Histology showed intact jejunal mucosa in the target group. The control group showed decreased number of mucin, globet cells, decreased height, and fragmentation of villi with the absence of intestinal glands. Markers of angiogenesis (CD34) were higher in the target group. In addition, markers of ischemia (LDH) (p = 0.0045) and inflammation (IL-1b, p = 0.0008, and IL-6, p = 0.0008) were significantly lower in the target group as compared with the control group. Conclusions In circumstances in which the recipient site does not offer an adequate and healthy bed or a vascular insult occurs, bowel flaps with less amount of serosa may be able to neovascularize faster thereby increasing its chances of survival.
PS8-11 The Effect of Rotator Cuff Imbalance during Glenohumeral Abduction(PS8: Poster Short Presentation VIII,Poster Session)
Matsuhashi, Tomoya , Sperling, John W. , Steinmann, Scott P. , An, Kai‐Nan, Iwasaki, Norisama

The Proceedings of the Asian Pacific Conference on Biomechanics : emerging science and technology in biomechanics | June 19, 2017 | Volume: 2015.8 | Pages: 363

10.1299/jsmeapbio.2015.8.363 Get It

EFFECT OF COLLAGEN CONCENTRATIONS ON THE CONTRACTION AND MATERIAL PROPERTIES OF BONE MARROW STROMAL CELL-SEEDED GEL(3A2 Cellular & Tissue Engineering & Biomaterials II)
Chieh, Hsiao-Feng, Omae, Hiromichi, Liao, Jiunn‐Der , An, Kai‐Nan, Sun, YuLong, Su, Fong‐Chin

The Proceedings of the Asian Pacific Conference on Biomechanics : emerging science and technology in biomechanics | June 19, 2017 | Volume: 2007.3 | Pages: S173

10.1299/jsmeapbio.2007.3.s173 Get It

Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72‐associated amyotrophic lateral sclerosis
Daughrity, Lillian M. , Diehl, Nancy N. , Wuu, Joanne , Miller, Timothy M. , Pástor, Pau , Trojanowski, John Q. , Hu, William T. , Ratti, Antonia , Benatar, Michael , Glass, Jonathan, Floeter, Mary Kay, Jeromin, Andreas, Petrucelli, Leonard , Group, the C9ORF72 Neurofilament Study, Toledo, Jon B. , Prudencio, Mercedes , Morelli, Claudia , Poletti, Barbara , Gendron, Tania F. , Boylan, Kevin B, Heckman, Michael G. , Grossman, Murray , Berry, James D. , Silani, Vincenzo , Boylan, Khrista , Group, the C9ORF72 Neurofilament Study, Prudencio, Mercedes , Poletti, Barbara , Pastor, Pau , Hu, William T.

Annals of Neurology | June 19, 2017 | Volume: 82 | Issue: 1 | Pages: 139-146

10.1002/ana.24980 | PMID 28628244 Get It

As potential treatments for C9ORF72‐associated amyotrophic lateral sclerosis (c9ALS) approach clinical trials, the identification of prognostic biomarkers for c9ALS becomes a priority. We show that levels of phosphorylated neurofilament heavy chain (pNFH) in cerebrospinal fluid (CSF) predict disease status and survival in c9ALS patients, and are largely stable over time. Moreover, c9ALS patients exhibit higher pNFH levels, more rapid disease progression, and shorter survival after disease onset than ALS patients without C9ORF72 expansions. These data support the use of CSF pNFH as a prognostic biomarker for clinical trials, which will increase the likelihood of successfully developing a treatment for c9ALS. Ann Neurol 2017;82:139–146
Neuromodulation in Postherpetic Neuralgia: Case Reports and Review of the Literature
Kurklinsky, Svetlana , Palmer, Scott C., Arroliga, Mack J, Ghazi, Salim M.

Pain Medicine | June 19, 2017 | Volume: 19 | Issue: 6 | Pages: 1237-1244

10.1093/pm/pnx175 | PMID 29016994 Get It

Expanded phenotypes and outcomes among 256 LGI 1/ CASPR 2‐ I g G
Gadoth, Avi , Pittock, Sean J. , Dubey, Divyanshu , McKeon, Andrew , Britton, Jeff W., Schmeling, John E., Smith, Aurelia, Watson, Robert E. , Flanagan, Eoin P. , Lennon, Vanda A. , Klein, Christopher J. , Kotsenas, Amy L. , Watson, Robert E , Pittock, S J , Britton, Jeffrey W. , Lachance, Daniel Honore , Flanagan, E P , Klein, Christopher J , McKeon, Andrew , Dubey, Divyanshu

Annals of Neurology | June 19, 2017 | Volume: 82 | Issue: 1 | Pages: 79-92

10.1002/ana.24979 | PMID 28628235 Get It

Objective To describe an expanded phenotypic spectrum and longitudinal outcome in 256 LGI1‐IgG–seropositive and/or CASPR2‐IgG–seropositive patients. Methods Patients were identified through service neural autoantibody evaluation. Ninety‐five had longitudinal follow‐up (7–456 months; median = 35). Results Among 3,910 patients tested, 196 were LGI1‐IgG positive, 51 were CASPR2‐IgG positive, and 9 were dual positive. Cerebrospinal fluid testing was less sensitive than serum testing, detecting only 24 of 38 (63%) LGI1‐IgG–positive and 5 of 6 (83%) CASPR2‐IgG–positive patients. LGI1‐IgG–positive specimens had higher voltage‐gated potassium channel–IgG immunoprecipitation values (0.33nmol/l, range = 0.02–5.14) than CASPR2‐IgG–positive specimens (0.10nmol/l, range = 0.00–0.45, p < 0.001). Of patients presenting with pain or peripheral nervous system (PNS) manifestations, 39% were LGI1‐IgG seropositive (7% had solely neuropathy or pain). Multivariate analysis identified age as the only significant predictor of central nervous system (CNS) versus PNS involvement (>50 years; odds ratio = 15, p < 0.001). Paroxysmal dizziness spells (PDS), a unique LGI1‐IgG accompaniment (14% of patients), frequently delayed the diagnosis. T2‐mesiotemporal hyperintensity was more common in LGI1‐IgG–positive (41%) than in CASPR2‐IgG–positive patients ( p = 0.033). T1‐bright basal ganglia were confined to LGI1‐IgG–positive patients with faciobrachial–dystonic seizures (9 of 39, 31%). Cancer was found in 44% of LGI1‐IgG/CASPR2‐IgG dual seropositive patients (one‐third thymoma). Response to initial immunotherapy was favorable in 97%; mean modified Rankin score was 3 (range = 1–5) at onset and 1.74 (range = 0–6) at last follow‐up, with 9% having severe refractory disability, 20% being asymptomatic, 28% receiving immunotherapy, and 58% receiving antiepileptic medication. Interpretation Older age is a strong predictor of CNS involvement in patients seropositive for CASPR2‐IgG or LGI1‐IgG. Pain, peripheral manifestations, and stereotypic paroxysmal dizziness spells are common with LGI1‐IgG. Response to initial immunotherapy is often favorable, but some patients remain severely disabled, requiring long‐term immunotherapy and/or antiepileptic medications. Ann Neurol 2017;82:79–92
Hydrogen–Deuterium Exchange Mass Spectrometry Reveals Calcium Binding Properties and Allosteric Regulation of Downstream Regulatory Element Antagonist Modulator (DREAM)
Zhang, Jun , Craig, Theodore A., Kumar, Rajiv , Gross, Michael L. , Gross, Michael L , Li, Jing , Kumar, Rajiv

Biochemistry | June 19, 2017 | Volume: 56 | Issue: 28 | Pages: 3523-3530

10.1021/acs.biochem.7b00100 | PMID 28627884 Get It

Abstract Downstream regulatory element antagonist modulator (DREAM) is an EF-hand Ca2+-binding protein that also binds to a specific DNA sequence, downstream regulatory elements (DRE), and thereby regulates transcription in a calcium-dependent fashion. DREAM binds to DRE in the absence of Ca2+ but detaches from DRE under Ca2+ stimulation, allowing gene expression. The Ca2+ binding properties of DREAM and the consequences of the binding on protein structure are key to understanding the function of DREAM. Here we describe the application of hydrogen–deuterium exchange mass spectrometry (HDX-MS) and site-directed mutagenesis to investigate the Ca2+ binding properties and the subsequent conformational changes of full-length DREAM. We demonstrate that all EF-hands undergo large conformation changes upon calcium binding even though the EF-1 hand is not capable of binding to Ca2+. Moreover, EF-2 is a lower-affinity site compared to EF-3 and -4 hands. Comparison of HDX profiles between wild-type DREAM and two EF-1 mutated constructs illustrates that the conformational changes in the EF-1 hand are induced by long-range structural interactions. HDX analyses also reveal a conformational change in an N-terminal leucine-charged residue-rich domain (LCD) remote from Ca2+-binding EF-hands. This LCD domain is responsible for the direct interaction between DREAM and cAMP response element-binding protein (CREB) and regulates the recruitment of the co-activator, CREB-binding protein. These long-range interactions strongly suggest how conformational changes transmit the Ca2+ signal to CREB-mediated gene transcription.
Toward the Development of a Glucose Dehydrogenase-Based Saliva Glucose Sensor Without the Need for Sample Preparation
Lin, Chi, Pratt, Breanna, Honikel, Mackenzie M. , Jenish, Alaina, Ramesh, Bhavna, Alkhan, Amnah, Belle, Jeffrey T. La , La Belle, Jeffrey T, Ramesh, Bhavna

Journal of Diabetes Science and Technology | June 19, 2017 | Volume: 12 | Issue: 1 | Pages: 83-89

10.1177/1932296817712526 | PMID 28627257 Get It

Background: Strict glycemic control is known to be a vital key in the management of diabetes mellitus (DM). However, traditional methods face limitations in their efficacy due to the pain and invasiveness of needle pricking which often discourages DM patients from performing the required number of tests per day. Saliva glucose (SG) sensing has long been considered a noninvasive alternative to blood glucose monitoring for diabetes management, however the sample preparation and sensor detection limit have been deemed as challenges to overcome. Herein, we describe a preliminary clinical validation of a disposable SG sensor without any requirement for sample preparation. Methods: The sensor utilizes glucose dehydrogenase flavine-adenine dinucleotide (GDH-FAD) in conjunction with disposable screen printed electrodes to measure glucose levels in saliva collected directly from 9 healthy subjects. Cyclic voltammetry and amperometric-time (Amp-it) assays were used to develop calibration curves and test subjects. Sensor calibration was performed using simulated saliva at 6.5 pH and 37ºC. Results: The lower limit of detection was determined to be 0.11 mg/dL. A lag time of 15 minutes with a positive correlation between SG and BG levels was found, which agrees with literature results. The detected SG ranges from 2.38 to 3.40 mg/dL over a BG range of 90 to 143 mg/dL. Conclusion: This is the first reported use of measuring SG with GDH-FAD without prior sample preparation. Upon optimization, the sensor has the potential to serve as a supplement to blood glucose monitoring.
Migraine Subclassification via a Data‐Driven Automated Approach Using Multimodality Factor Mixture Modeling of Brain Structure Measurements
Si, Bing , Li, Jing , Schwedt, Todd J. , Wu, Teresa , Chong, Catherine D. , Si, Bing

Headache: The Journal of Head and Face Pain | June 19, 2017 | Volume: 57 | Issue: 7 | Pages: 1051-1064

10.1111/head.13121 | PMID 28627714 Get It

Background The current subclassification of migraine is according to headache frequency and aura status. The variability in migraine symptoms, disease course, and response to treatment suggest the presence of additional heterogeneity or subclasses within migraine. Objective The study objective was to subclassify migraine via a data‐driven approach, identifying latent factors by jointly exploiting multiple sets of brain structural features obtained via magnetic resonance imaging (MRI). Methods Migraineurs ( n = 66) and healthy controls ( n = 54) had brain MRI measurements of cortical thickness, cortical surface area, and volumes for 68 regions. A multimodality factor mixture model was used to subclassify MRIs and to determine the brain structural factors that most contributed to the subclassification. Clinical characteristics of subjects in each subgroup were compared. Results Automated MRI classification divided the subjects into two subgroups. Migraineurs in subgroup #1 had more severe allodynia symptoms during migraines (6.1 ± 5.3 vs. 3.6 ± 3.2, P = .03), more years with migraine (19.2 ± 11.3 years vs 13 ± 8.3 years, P = .01), and higher Migraine Disability Assessment (MIDAS) scores (25 ± 22.9 vs 15.7 ± 12.2, P = .04). There were not differences in headache frequency or migraine aura status between the two subgroups. Conclusions Data‐driven subclassification of brain MRIs based upon structural measurements identified two subgroups. Amongst migraineurs, the subgroups differed in allodynia symptom severity, years with migraine, and migraine‐related disability. Since allodynia is associated with this imaging‐based subclassification of migraine and prior publications suggest that allodynia impacts migraine treatment response and disease prognosis, future migraine diagnostic criteria could consider allodynia when defining migraine subgroups.
Chest X-ray of a patient with history of pleural effusion
Konik, Ewa, Schirger, John A., Schirger, John

BMJ Case Reports | June 19, 2017 | Volume: 2017 | Issue: No issue available | Pages: bcr-2017-220769

10.1136/bcr-2017-220769 | PMID 28630248 Get It

The presented chest X-ray depicts the thoracic duct anatomy of a 50-year-old man who underwent heart transplantation. His postoperative course was complicated by Candida mediastinitis, treated with débridements and closure of the anterior chest wound with myocutaneous flaps. Postoperatively, he had persistent output from a right-sided chest tube. The fluid appeared milky and its triglycerides level was elevated at 254 mg/dL. The drainage persisted despite a low fat diet. The interventional radiologist identified a leak in the upper thoracic duct. It was embolised with coil and onyx. After the procedure, the chylous pleural effusions resolved. The thoracic duct has been visualised on subsequent chest X-rays (figures 1 and 2).